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ARTICLE
IgSF21 promotes differentiation of inhibitory
synapses via binding to neurexin2α
Yuko Tanabe1, Yusuke Naito1,2, Cristina Vasuta1, Alfred Kihoon Lee1,2, Youssouf Soumounou1,
Michael W. Linhoff3,4,5 & Hideto Takahashi1,2,6,7
Coordinated development of excitatory and inhibitory synapses is essential for higher
brain function, and impairment in this development is associated with neuropsychiatric
disorders. In contrast to the large body of accumulated evidence regarding excitatory
synapse development, little is known about synaptic adhesion and organization
mechanisms underlying inhibitory synapse development. Through unbiased expression
screens and proteomics, we identiﬁed immunoglobulin superfamily member 21 (IgSF21) as a
neurexin2α-interacting membrane protein that selectively induces inhibitory presynaptic
differentiation. IgSF21 localizes postsynaptically and recruits axonal neurexin2α in a trans-
interaction manner. Deleting IgSF21 in mice impairs inhibitory presynaptic organization,
especially in the hippocampal CA1 stratum radiatum, and also diminishes GABA-mediated
synaptic transmission in hippocampal CA1 neurons without affecting their excitatory
synapses. Finally, mice lacking IgSF21 show a sensorimotor gating deﬁcit. These ﬁndings
suggest that IgSF21 selectively regulates inhibitory presynaptic differentiation through
interacting with presynaptic neurexin2α and plays a crucial role in synaptic inhibition in the
brain.
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γ-Aminobutyric acid (GABA)-mediated synaptic transmis-sion determines neuronal excitability and the ﬁring
patterns of target neurons1 and also regulates neuronal
circuit formation2–5. In the mature brain, each neuron receives
excitatory and inhibitory synaptic inputs from glutamatergic
neurons and GABAergic interneurons, respectively, and a
proper balance between these inputs is needed to maintain
normal brain functions6, 7. To ﬁne-tune neuronal excitability,
GABAergic innervation is complex with different types of inter-
neurons forming inhibitory synapses in a cell type-speciﬁc and
compartment-speciﬁc manner8–11. The mechanisms underlying
the development of these complex GABAergic innervation
patterns are poorly understood. Recent evidence indicates
that impaired development of central inhibitory synapses is
fundamental to the etiology of neuropsychiatric disorders such
as schizophrenia12, 13, autism spectrum disorders (ASD)7, 14 and
anxiety15. Thus, the importance of expanding our understanding
of the molecular mechanisms of GABAergic synapse develop-
ment has been highlighted in recent years.
Synapse development requires not only physical contact
between axons and target neurons but also chemically matched
presynaptic and postsynaptic differentiation16, 17. Synapse
organizing complexes, trans-synaptic adhesion complexes with
the ability to induce synaptic differentiation, act as essential
molecular signals for synapse development18–21. The neuroligin
(NLG)–neurexin (NRX) complex is the best-studied synapse
organizing complex19, 22, but there are many others including
LRRTMs-NRXs23, 24, GluRδ-cerebellin-NRXs25, 26, TrkC-
PTPσ27, 28, Slitrks-PTPδ/σ29, 30 and NGL3-LAR31. Notably, only
Slitrk3-containing and NLG2/4-containing complexes have been
reported to function selectively or preferentially in inhibitory
synapse development29, 30, 32–34.
The relatively sparse identiﬁcation of synapse organizing
complexes selectively regulating inhibitory synapse development
could be due in part to the complex nature of GABAergic inter-
neuron innervation8–11. Neuronal circuits contain many types of
GABAergic interneurons, and distinct subtypes innervate speciﬁc
subcellular compartments of target neurons (the dendrites, the
soma, or the axon initial segment), consequently providing multi-
faceted inhibitory impacts8, 11. The heterogeneous nature of
GABAergic synaptic connections suggests that there must be many
types of adhesion complexes regulating inhibitory synapses.
To identify novel synapse organizing proteins, an artiﬁcial
synapse formation assay using ﬁbroblast-neuron co-cultures to
visualize the synapse-inducing (“synaptogenic”) activity of
molecules of interest was utilized18, 23, 27, 35. Combining this assay
with a rat brain cDNA library in an unbiased screen isolated a few
novel synapse organizers including LRRTM123, TrkC27, and
calsyntenin-335. Here, we report the additional isolation of
immunoglobulin superfamily member 21 (IgSF21) as a novel
synaptogenic membrane protein that induces inhibitory, but not
excitatory, presynaptic differentiation. Through another unbiased
proteomics screen, we isolated NRX2α as an IgSF21-interacting
presynaptic organizer. IgSF21 recruits NRX2α to presynaptic sites
in a trans-interaction manner and this interaction is essential for
the synaptogenic activity of IgSF21. To date, there is no published
study characterizing the physiological roles of IgSF21. Thus,
to investigate its function in the central nervous system, we
generated and comprehensively characterized IgSF21 mutant
mice. We found that IgSF21 positively controls inhibitory
presynaptic organization and GABA-mediated synaptic trans-
mission in the hippocampal CA1 pyramidal neurons and that
IgSF21 is required for normal sensorimotor gating. Together, our
results suggest that IgSF21 selectively organizes inhibitory
synapses through its trans-synaptic interaction with axonal
NRX2α and that this is important for normal brain function.
Results
Inhibitory presynaptic differentiation induced by IgSF21. To
identify novel synaptogenic molecules, we performed an unbiased
expression screen based on an artiﬁcial synapse formation assay
in which hippocampal neurons are cocultured with ﬁbroblasts
transfected with rat brain cDNA library pools23, 27, 35. From the
positive pool PB243, we isolated IgSF21 as a synaptogenic clone,
as assessed by the accumulation of the presynaptic marker
synapsin I in the coculture assay (Supplementary Fig. 1a, b).
IgSF21 has two extracellular immunoglobulin-like domains
(Ig1 and Ig2) and a putative C-terminal signal sequence for a
glycosylphosphatidylinositol (GPI)-anchor modiﬁcation but no
transmembrane domain (Fig. 1a and Supplementary Fig. 1c, d).
IgSF21 is expressed on the cell surface but can be stripped
from the surface using phosphatidylinositol-speciﬁc phospholi-
pase C (PI-PLC), conﬁrming that IgSF21 is a GPI-anchored
protein (Supplementary Fig. 1e, f). Igsf21 is a vertebrate-speciﬁc
gene whose Ig domains are highly conserved between
species (Supplementary Fig. 1c, d). Mice express at least
two IgSF21 isoforms; one is a homolog (mIgSF21) of rat
IgSF21 (rIgSF21) with a longer linker between the two Ig domains
and the other is an alternatively spliced isoform with a shorter
linker (mIgSF21-S). Thus, we next tested whether each IgSF21
isoform induces excitatory and/or inhibitory presynaptic
differentiation in coculture assays using HEK293 cells expressing
HA-tagged IgSF21 proteins. Notably, rIgSF21, mIgSF21 and
mIgSF21-S all induced the accumulation of VGAT, an inhibitory
(GABAergic) presynaptic marker, but not that of VGLUT1, an
excitatory (glutamatergic) presynaptic marker, at contacting
axons of hippocampal neurons (Fig. 1b–e) or cortical neurons
(Supplementary Fig. 2a–d), indicating that IgSF21 selectively
induces inhibitory presynaptic differentiation. For the remainder
of this study, we focused on the IgSF21 isoform with a longer
linker because the synaptogenic activity of mIgSF21-S was very
weak (Fig. 1c) although surface expression of mIgSF21-S is
comparable to that of mIgSF21 (Supplementary Fig. 3a). IgSF21
also induced the uptake of an antibody directed against the
synaptotagmin I luminal domain (SynTag; Fig. 1f, g), which
occurs only during active recycling of synaptic vesicles (SVs),
suggesting that IgSF21 induces functional presynaptic differ-
entiation. On the other hand, IgSF21 did not induce the accu-
mulation of either gephyrin or PSD-95 in contacting dendrites
(Supplementary Fig. 2e–h), showing that IgSF21 has no post-
synaptic induction activity. We further determined the domain
responsible for IgSF21 synaptogenic activity using deletion con-
structs in the coculture assay. IgSF21 lacking Ig1 did not induce
VGAT accumulation whereas IgSF21 lacking Ig2 did but had
only about half the synaptogenic activity of full-length IgSF21
(Fig. 1h, i). There was no difference in surface expression of
full-length IgSF21, IgSF21 lacking Ig1 or IgSF21 lacking Ig2
(Supplementary Fig. 3b), indicating that the differences in their
synaptogenic activity are not due to differing surface expression
levels. These results demonstrate that the Ig1 domain of IgSF21 is
indispensable for synaptogenic activity whereas its Ig2 domain is
secondarily responsible for the activity. Thus, IgSF21 selectively
induces the differentiation of functional inhibitory presynaptic
terminals primarily through its Ig1 domain.
IgSF21 expression and localization. We next examined the
expression pattern of IgSF21 in mouse tissues. Immunoblot
analysis revealed that the long form of IgSF21 (~60 kDa) is
predominantly expressed in the brain, whereas the IgSF21 short
isoform (~35 kDa) is also expressed in other organs (Fig. 2a).
IgSF21 is expressed in the brain at both embryonic and postnatal
stages including the adult stage (Fig. 2b). In particular, the period
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of highest expression of the long isoform is at around two
postnatal weeks, coinciding with the peak period of synapto-
genesis. IgSF21 displays fairly broad expression in the brain: it is
expressed in the cortex and the hippocampus as well as other
brain regions (Fig. 2c). To more precisely assess Igsf21 gene
expression, we generated mice in which a gene trap cassette
containing a LacZ reporter gene with a splicing acceptor was
inserted into the Igsf21 locus36 (Supplementary Fig. 4a–c). In
mice heterozygous for this allele (Igsf21+/−(LacZ)), β-galactosidase
encoded by the LacZ gene is expressed under the control of the
Igsf21 promoter, allowing us to analyze Igsf21 expression
by examining β-gal enzymatic activity using X-gal as a substrate.
The X-gal staining of brain sections from these mice
demonstrated that at four postnatal weeks, the Igsf21 gene is
highly expressed in the pyramidal cell layer of the dorsal and
ventral hippocampal CA1 and CA3 regions (Fig. 2d and
Supplementary Fig. 5a), layers 5 and 6 of the cortex (Fig. 2d and
Supplementary Fig. 5b), the thalamus and the pons (Fig. 2d) and
weakly expressed in the cerebellum (Fig. 2d and Supplementary
Fig. 5c).
At the cellular level, IgSF21 is expressed in neurons but not in
glia (Fig. 2e). Upon fractionation of mouse brains, IgSF21 protein
is present in the synaptosome and postsynaptic density (PSD)
fractions (Fig. 2f), indicating that IgSF21 is localized postsynapti-
cally in neurons. We further investigated the subcellular
localization of IgSF21 by expressing a construct consisting of
IgSF21 tagged with HA (IgSF21-HA) in hippocampal neurons.
IgSF21-HA predominantly targeted to dendrites but also to
axons (Supplementary Fig. 6a, b). IgSF21-HA also exhibited
a diffuse distribution with a punctate pattern in dendrites.
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Fig. 1 IgSF21 induces functional inhibitory presynaptic differentiation in coculture assays. a Domain structure of IgSF21. IgSF21 has two immunoglobulin-like
domains (Ig1 and Ig2), an N-terminal signal peptide (Sp) and a C-terminal signal peptide for glycosylphosphatidylinositol (GPI)-anchor modiﬁcation (GPI-
anchor). b, d HEK293 cells expressing mouse IgSF21 tagged with HA (mIgSF21-HA) induce clustering of VGAT b, but not that of VGLUT1 d, along
contacting axons (labeled with dephosphorylated tau) in hippocampal neuron cultures. HEK293 cells expressing HA-CD4 as a negative control do not
induce clustering of either VGAT or VGLUT1. c, e Quantiﬁcation of the total intensity of VGAT c and VGLUT1 e puncta associated with HEK293
cells expressing the indicated HA-tagged proteins and not associated with MAP2 divided by tau-positive axon-contact area, expressed as a percentage
of the value for the HA-neuroligin2 (HA-NLG2) positive control. n≥ 20 cells for each construct from three independent experiments, Kruskal–Wallis
one-way ANOVA, P< 0.0001 for VGAT and VGLUT1. #P= 0.0112 and ***P< 0.0001 compared with HA-CD4 by Dunn’s multiple comparisons test.
f, g HEK293 cells expressing mIgSF21-HA induce presynaptic terminals with active synaptic vesicle recycling, as assessed by incubating live neurons
with antibodies recognizing the synaptotagmin I (SynTag) luminal domain. mIgSF21-HA, but not HA-CD4, induces SynTag uptake (red) associated
with VGAT accumulation (green). n> 25 cells for each construct from three independent experiments, Mann–Whitney test, ***P< 0.0001. h, i HEK293
cells expressing mIgSF21 lacking the Ig1 domain (ΔIg1) do not induce VGAT clustering. n≥ 20 cells for each construct from three independent
experiments, Kruskal–Wallis one-way ANOVA, P< 0.0001. ***P< 0.0001 compared with HA-CD4 by Dunn’s multiple comparisons test. n.s., not
signiﬁcant. Scale bars represent 20 μm b, d, f, h. Data are presented as mean± s.e.m
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Some IgSF21-HA puncta on dendrites were juxtaposed to and/or
overlapped with a subset of VGAT puncta. IgSF21-HA puncta on
dendrites were associated signiﬁcantly more with VGAT puncta
than with VGLUT1 puncta (Supplementary Fig. 6c, d). Together
these data suggest that IgSF21 accumulates at postsynaptic sites of
a subset of inhibitory synapses.
Selective interaction of IgSF21 with Neurexin2α. To identify
IgSF21-interacting presynaptic organizers, we performed
an unbiased proteomics screen using protein-A sepharose
magnetic beads coated with recombinant IgSF21 fused to the
human immunoglobulin Fc region (IgSF21-Fc) (Supplementary
Fig. 7). We applied IgSF21-Fc-coated magnetic beads onto
hippocampal neuron cultures. First, we observed that IgSF21-Fc-
coated beads induced the accumulation of VGAT
but not VGLUT1 (Supplementary Fig. 7a–c), conﬁrming that
the IgSF21-Fc recombinant protein retains selective inhibitory
presynaptic differentiation activity. We then performed
protein crosslinkage of surface-bound proteins to IgSF21-Fc
using non-permeable 3,3ʹ-dithiobis(sulfosuccinimidyl propionate)
(DTSSP). Our proteomics analysis identiﬁed NRX2α and PTPσ as
membrane proteins pulled down by IgSF21-Fc-coated beads
(Supplementary Fig. 7d–f). In a cell surface binding assay, we
determined that IgSF21-Fc interacts with NRX2α but not PTPσ
(Fig. 3a, b).
We next determined which of the many NRX family
isoforms37 interact with IgSF21. Interestingly, IgSF21-Fc inter-
acted only with NRX2α and not with any other NRX isoforms
(Fig. 3a, b). The binding of IgSF21-Fc with NRX2α is at high
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Fig. 2 The long isoform of IgSF21 is preferentially expressed in the brain and localized at postsynaptic sites in neurons. a Expression of IgSF21 protein in
mouse tissue at two postnatal weeks. Western blots show the preferential expression of the IgSF21 long isoform in the brain. Sk. muscle, skeletal muscle.
b Expression of IgSF21 protein during mouse brain development. IgSF21 is highly expressed at 2–3 postnatal weeks and remains expressed in the adult.
E, embryonic; P, postnatal. c Expression of IgSF21 protein in several mouse brain regions at four postnatal weeks. Cx, cortex; Hp, hippocampus;
Cb, cerebellum; Other, other brain regions. d Images of X-gal staining of Igsf21+/−(LacZ) mouse brain at four postnatal weeks show that the Igsf21 gene is
preferentially expressed in the deep layers of the cortex (Cx), the pyramidal cell layer of the CA1 and CA3 regions of the hippocampus (Hp; left image,
CA1, CA3; right image), the thalamus (Th), and the pons (P). e Immunoblot of cell lysates from relatively pure primary glial cultures and mixed cultures of
glial cells and neurons. IgSF21 is expressed in neurons but not glial cells. Tuj1, a neuron-speciﬁc class III β-tubulin; GFAP, glial ﬁbrillary acid protein.
f Expression of IgSF21 protein in mouse brain fractions at three postnatal weeks. IgSF21 is enriched in the crude synaptosome (P2 and P2’), synaptosome
(Sy) and postsynaptic density (PSD) fractions. H, homogenate; S1, supernatant 1; Cy, cytoplasm. Scale bars represent 2 mm (d, left) and 500 μm (d, right).
Arrow, IgSF21 (~60 kDa); * non-speciﬁc bands. Uncropped blots for a, b, c, e and f are shown in Supplementary Fig. 10
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afﬁnity (Kd= 21.0 nM) (Fig. 3c) and is independent of
extracellular calcium and is unlikely to require inserts at any of
the NRX2α-splicing sites, S1-S4 (Supplementary Fig. 8a–c).
We further determined the domain of NRX2α that is responsible
for IgSF21 binding by deletion analysis. The ﬁrst LNS
(laminin, neurexin and sex hormone-binding globulin-like)
domain (LNS1) of NRX2α was necessary and sufﬁcient for
IgSF21-binding (Supplementary Fig. 8d, e). Conversely, IgSF21
Ig1 was necessary for NRX2α-binding and IgSF21 Ig2
was dispensable for NRX2α-binding (Fig. 3d, e). Thus, the Ig1
domain of IgSF21 is primarily responsible for both IgSF21
synaptogenic activity (Fig. 1h, i) and NRX2α interaction
(Fig. 3d, e), suggesting that NRX2α acts as a functional IgSF21
receptor. Further, in an artiﬁcial synapse formation assay, VGAT
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c Scatchard plot analysis shows that the Kd for the binding of IgSF21-Fc to HA-NRX2αS4(-) is 21.0 nM (n= 30 cells). d, e NRX2α-Fc binds to rat and mouse
full-length IgSF21-HA (rIgSF21-HA, mIgSF21-HA), the mIgSF21-short isoform (mIgSF21S)-HA and mIgSF21-HA lacking Ig2 (ΔIg2), but not to mIgSF21-HA
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beads for each condition from three independent experiments, Mann–Whitney test, ***P< 0.0001. Scale bars represent 30 μm a, d and 10 μm f, h. Data are
presented as mean± s.e.m
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accumulation induced by mIgSF21-HA was signiﬁcantly
inhibited by the addition of soluble NRX2α-Fc to the coculture
medium (Fig. 3f, g). This conﬁrms that IgSF21-NRX2α interac-
tion is involved in the synaptogenic activity of IgSF21. Next,
we tested whether IgSF21 can recruit axonal NRX2α by
adding IgSF21-Fc-coated beads onto hippocampal neurons
expressing HA-tagged NRX2α (HA-NRX2α). IgSF21-Fc-coated
beads induced strong accumulation of HA-NRX2α in contacting
transfected axons, whereas Fc-coated beads (a negative control)
did not (Fig. 3h, i). Together, these data indicate that IgSF21
binds and recruits axonal NRX2α in a trans-interaction manner
and that this interaction is essential for the synaptogenic activity
of IgSF21.
Impaired inhibitory synaptic organization in Igsf21−/− mice.
To investigate the in vivo roles of endogenous IgSF21 in synapse
organization, we analyzed IgSF21 homozygous mutant mice
(Igsf21−/−) generated by a gene trapping strategy36 (Supplemen-
tary Fig. 4a–c). We conﬁrmed complete loss of mIgSF21 and
mIgSF21-S protein expression in the Igsf21−/− mouse brain by
immunoblotting (Fig. 4a) and loss of mRNAs encoding mIgSF21,
mIgSF21-S and any other possible IgSF21 isoforms possessing
Ig1 by RT-PCR (Supplementary Fig. 4d, e).
Igsf21−/−mice grew normally (Supplementary Fig. 4f) and bore
no gross brain abnormalities including in the hippocampus
(Fig. 4b). We next checked the levels of synaptic proteins in
the synaptosomal fraction of the cerebral cortex. Immunoblot
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analysis showed that synaptosomes from Igsf21−/−mice contained
less VGAT and gephyrin than those from wild-type (Igsf21+/+)
mice but there were no changes in the levels of other synaptic
proteins including GABAA receptors and excitatory synaptic
proteins such as VGLUT1, PSD-95 and glutamate receptors
(Fig. 4c, d). There were no changes in the NLG1, 2 and 3 levels
(Fig. 4c, d), indicating that the reduction of VGAT and gephyrin
in the Igsf21−/− synaptosome fraction cannot be due to a
reduction in NLG1/2/3 expression. Thus, deleting IgSF21 causes
selective deﬁcits in synaptosomal inhibitory synaptic components.
A similar reduction of VGAT, but not gephyrin, GABAA receptor
γ2 subunit, VGLUT1, PSD-95 or NLG2, occurs in synaptosomes
from the hippocampus of Igsf21−/−mice (Fig. 4c, d).
We next performed immunohistochemistry on coronal brain
sections from Igsf21−/−mice. Given that the Igsf21 gene is highly
expressed in layers 5 and 6 of the cerebral cortex (Supplementary
Fig. 5b), we ﬁrst analyzed immunoﬂuorescence for inhibitory
synaptic markers in layer 5 of the somatosensory cortex.
Consistent with the immunoblot analysis (Fig. 4c, d), Igsf21−/−
mice had a signiﬁcant decrease in immunoreactivity for
VGAT and gephyrin in layer 5 of the somatosensory cortex
(Supplementary Fig. 9a, b).
To further assess synaptic deﬁcits in the Igsf21−/− mice,
we focused on the CA1 hippocampus because the Igsf21 gene
is signiﬁcantly expressed in the CA1 region and because
this region allows for easy segregation of the somatic and
dendritic regions of pyramidal neurons. In double immunostain-
ing analysis of the CA1 stratum radiatum, which contains
mainly dendritic synapses, the total intensity of VGAT
puncta was 20% lower in Igsf21−/−mice than in Igsf21+/+
littermates in the dorsal hippocampus (Fig. 5a, b) and in
the ventral hippocampus (Fig. 5d, e), while there was no
difference in total VGLUT1 intensity (Fig. 5a, c, d, f). Notably,
no change in VGAT expression was detected in the stratum
pyramidale (Fig. 5a, b, d, e), which contains mainly perisomatic
synapses. These data therefore suggest that Igsf21−/− mice may
display impaired formation of inhibitory synapses and/or
impaired organization of inhibitory presynaptic terminals,
especially in the CA1 stratum radiatum of both the dorsal and
the ventral hippocampus.
Using electron microscopy, we further investigated the number
of symmetric and asymmetric synapses in the stratum radiatum
and the stratum pyramidale of the dorsal hippocampal
CA1 region in Igsf21−/− mice (Fig. 6a, b). Generally, symmetric
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and asymmetric synapses correspond to inhibitory and excitatory
synapses, respectively38. There was no difference in the
number of symmetric or asymmetric synapses in the stratum
pyramidale or stratum radiatum (Fig. 6a, b). This suggests
that IgSF21 is dispensable for the formation of both inhibitory
and excitatory synapses. To investigate whether IgSF21 plays
a role in the organization of inhibitory presynaptic terminals,
we next counted the number of total and docked SVs per bouton
in symmetric synapses on dendrites in the stratum radiatum
(Fig. 6c, d). Notably, the presynaptic boutons of symmetric
synapses on dendrites in Igsf21−/− mice possessed far fewer
total and docked SVs than those in Igsf21+/+ littermates
(P< 0.0001 for total SVs and P= 0.0001 for docked SVs)
(Fig. 6c, d). In contrast, there was no difference in the number
of total or docked SVs at presynaptic boutons of asymmetric
synapses in the stratum radiatum of Igsf21−/− and Igsf21+/+
littermates (Fig. 6c, d). In the presynaptic boutons of symmetric
synapses on perisomatic regions in the stratum pyramidale, there
was no difference in the number of total SVs (P= 0.24) but a
slight decrease in the number of docked SVs (P= 0.0038) (Fig. 6c,
d). Together, these results indicate that deleting IgSF21 impairs
presynaptic organization of inhibitory, but not excitatory,
synapses and preferentially affects those on dendrites in the
stratum radiatum.
Impaired inhibitory synaptic transmission in Igsf21−/− mice.
To investigate the effects of IgSF21 knockout on inhibitory
synaptic function, we recorded miniature inhibitory and
excitatory postsynaptic currents (mIPSCs and mEPSCs,
respectively) from hippocampal CA1 pyramidal neurons in acute
slices from Igsf21−/− and Igsf21+/+ littermates (Fig. 7). mIPSC
frequency was signiﬁcantly decreased (corresponding to an
increased inter-event interval) in Igsf21−/− mice relative to
Igsf21+/+ littermates (Fig. 7a, b). However, there was no difference
in mIPSC amplitude in Igsf21−/− and Igsf21+/+mice (Fig. 7a, c),
as well as no difference in mEPSC frequency or amplitude
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(Fig. 7d–f). In principle, a decrease in mIPSC frequency
could arise from a decrease in presynaptic GABA release
probability, a decrease in the number of inhibitory synapses
and/or, indirectly, a decrease in mIPSC amplitudes; however,
these latter two possibilities can be eliminated as there was no
change in inhibitory synapse number (Fig. 6a, b) or mIPSC
amplitude (Fig. 7a, c). Thus, the reduced mIPSC frequency
in Igsf21−/− mice suggests a decreased probability of presynaptic
GABA release. Together with our observation of SV reduction in
inhibitory presynaptic terminals in Igsf21−/− mice (Fig. 6c, d),
these data indicate that IgSF21 regulates inhibitory synaptic
transmission by controlling presynaptic function at inhibitory
synapses.
Impaired sensorimotor gating in Igsf21−/− mice. To address
whether IgSF21 is involved in brain functions, we performed
behavioral assessment of sensorimotor processes in the Igsf21−/−
mice by examining four general behaviors: open-ﬁeld exploratory
locomotion, rotarod performance, the acoustic startle reﬂex
and prepulse inhibition (PPI) of the acoustic startle reﬂex, a
measure of sensorimotor gating (the process of ﬁltering out
unimportant stimuli in the sensory environment)39–41. In the
open ﬁeld test, there was no difference in the total distance
traveled by the Igsf21−/− and Igsf21+/+ littermates (Fig. 8a). Also,
Igsf21−/− and Igsf21+/+ littermates had comparable latency to
fall in the rotarod test (Fig. 8b). Thus, IgSF21 knockout had no
effect on motor activity and coordination. In addition, Igsf21−/−
and Igsf21+/+ littermates displayed comparable amplitudes of
the acoustic startle reﬂex (Fig. 8c). Interestingly, Igsf21−/−
mice showed a signiﬁcant reduction in PPI of the acoustic startle
reﬂex (Fig. 8d). Thus, deleting IgSF21 impaired sensorimotor
gating with no effect on motor activity and coordination.
Discussion
In this study, we identiﬁed IgSF21 as a GPI-anchored
membrane protein that selectively promotes inhibitory
presynaptic differentiation. We further isolated NRX2α as an
IgSF21-interacting presynaptic organizer through an unbiased
proteomics screen. Our data showed that IgSF21 selectively
interacts with NRX2α via its synaptogenic domain (Ig1) and
recruits axonal NRX2α in a trans-interaction manner, providing
molecular and cellular mechanisms by which IgSF21 induces
inhibitory presynaptic differentiation through trans-synaptic
adhesion. Our comprehensive analysis of Igsf21−/− mice
revealed that in hippocampal CA1 pyramidal neurons, IgSF21
controls presynaptic organization of inhibitory synapses, espe-
cially those in the stratum radiatum, and that this control is
crucial for normal GABA-mediated synaptic transmission.
Accordingly, our behavioral experiments demonstrate that Igsf21
−/− mice display impaired sensorimotor gating. Together, these
data suggest that the IgSF21–NRX2α complex is essential for the
differentiation of inhibitory presynaptic terminals on hippo-
campal CA1 pyramidal neurons and is indispensable for normal
brain function.
Although numerous previous efforts have identiﬁed
many synapse organizing complexes19–31, few of these
regulate inhibitory synapse organization, either selectively or
preferentially29, 30, 32–34. Here we show that IgSF21 promotes
inhibitory, but not excitatory, presynaptic differentiation in
cultured neurons, as Slitrk3 does29. However, in the hippocampal
CA1 region, Slitrk3 knockout impairs inhibitory synapse orga-
nization in both the stratum radiatum and the stratum
pyramidale29, while IgSF21 knockout impairs inhibitory synapse
organization mainly in the stratum radiatum and very subtly in
the stratum pyramidale. Knockout of NLG2, another inhibitory
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synapse organizer, impairs inhibitory synaptic organization in the
hippocampal CA1 stratum pyramidale but not in the stratum
radiatum32. Thus the most signiﬁcant ﬁnding of this study is the
identiﬁcation of IgSF21 as a novel inhibitory synapse-speciﬁc
organizer that works differently from previously identiﬁed
inhibitory synapse organizers. The hippocampus8 and the cere-
bral cortex11 contain many different types of GABAergic inter-
neurons whose axons tend to innervate speciﬁc subcellular
compartments of target pyramidal neurons (the dendrite, the
soma or the axon initial segment). Given that the stratum
radiatum and the stratum pyramidale mainly contain dendritic
and perisomatic inhibitory synapses on CA1 pyramidal neurons,
respectively, IgSF21 may regulate presynaptic differentiation of
inhibitory synapses innervated by speciﬁc subsets of GABAergic
interneurons: those that mainly mediate dendritic inhibition.
Examples of such interneurons include bistratiﬁed cells and
Schaffer collateral-associated cells that preferentially innervate
dendrites of CA1 pyramidal neurons in the stratum radiatum8, 42.
Interneuron-subtype speciﬁcity for IgSF21 synaptogenic activity
remains an interesting question, and future studies using methods
such as artiﬁcial synapse formation assays in neuron cultures
from conditional mutant mice with interneuron type-speciﬁc
deletion of NRX2α would help clarify this important aspect of
synapse organization.
The molecular basis for the selectivity of IgSF21 for inhibitory
presynaptic differentiation may lie in its partner binding
speciﬁcity. NLG2 and calsyntenin-3 have been characterized
as NRX-binding synapse organizers that regulate inhibitory
synapse development in the hippocampal CA1 region although
calsyntenin-3 also regulates excitatory synapse development35.
NLG2 binds both the α-isoform and β-isoform of NRX1/2/319,
whereas calsyntenin-3 binds only the α-isoform of NRX1/2/335.
In contrast, IgSF21 binds only NRX2α and no other isoforms.
In coculture assays, NLG2 and calsyntenin-3 induce both
inhibitory and excitatory presynaptic differentiation27, 29, 35
whereas IgSF21 induces inhibitory presynaptic differentiation
exclusively. Similarly, while calsyntenin-3 knockout affects
both excitatory and inhibitory synapse organization35, IgSF21
knockout selectively affects inhibitory synapse organization.
These ﬁndings suggest that IgSF21 acts solely at inhibitory
synapses due to its speciﬁc binding to NRX2α. Several
NRX2α-based mechanisms that could underlie this speciﬁcity
can already be eliminated. Restricted expression of NRX2α to
GABAergic interneurons is an unlikely mechanism because
NRX2α mRNA is expressed in all types of hippocampal neurons
including pyramidal neurons37. Many molecular interactions
with NRX depend on NRX-splicing19, 22; however, IgSF21
binds to NRX2α LNS1 regardless of NRX2α splice variation.
Other less obvious mechanisms must be at play. For example,
glutamatergic axons could express IgSF21 synaptogenic
suppressors that bind to NRX2α. Or, GABAergic, but not
glutamatergic, axons could express NRX2α-interacting coactiva-
tors of IgSF21 activity. Proteomics-based global identiﬁcation
of NRX2α-interacting proteins would be helpful to test
these possibilities.
Our domain analyses revealed that IgSF21 Ig1 is indispensable
for both IgSF21–NRX2α interaction and IgSF21 synaptogen-
icactivity. In contrast, IgSF21 Ig2 is dispensable for
IgSF21–NRX2α interaction but is partly responsible for
IgSF21 synaptogenic activity. Further, the IgSF21 splicing isoform
with a shorter linker between Ig1 and Ig2 displays not quite half
the synaptogenic activity of the IgSF21 isoform with a longer
linker although both isoforms possess the exact same Ig1 and Ig2
domains. These ﬁndings suggest that synaptogenic activity of
IgSF21 requires not only NRX2α binding (Ig1-dependent
mechanism) but also other mechanisms that depend on Ig2 and
the spliced linker. Synaptogenic activity of NLG1 requires NLG1
dimerization as well as NLG1–NRX interaction43, 44. In addition,
synaptogenic activity of Slitrk1 requires not only Slitrk1–PTPδ
interaction but also the lateral assembly of Slitrk1–PTPδ
complexes45. Thus, the synaptogenic activity of IgSF21 may
require IgSF21 dimerization or the lateral assembly of
IgSF21–NRX2α complexes through its Ig2 domain and/or its
linker. A future study of the crystal structure of the
IgSF21–NRX2α complex will be needed to understand the
structural basis for its synaptogenic activity.
A previous time-lapse imaging study has shown that inhibitory
synapses exhibit coordinated organization of their presynaptic
and postsynaptic sites46. However, our biochemical data
show that hippocampal synaptosomes in Igsf21−/− mice contain
decreased levels of VGAT but exhibit no signiﬁcant reduction of
the GABAA receptor γ2 subunit or of gephyrin, a postsynaptic
scaffold for GABAA receptors47. Further, the hippocampal
CA1 pyramidal neurons in Igsf21−/− mice have reduced mIPSC
frequency but normal mIPSC amplitudes, indicating a reduction
of quantal GABA release as a presynaptic effect of IgSF21.
Our electron microscopy data also show that there is no reduction
in the number of perisomatic and dendritic inhibitory
synapses in Igsf21−/−CA1 neurons but that these inhibitory
synapses contain fewer total and/or docked SVs. These ﬁndings
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Fig. 8 Igsf21−/− mice have a sensorimotor gating deﬁcit. a There is no
difference between Igsf21+/+ and Igsf21−/− littermates in the total distance
traveled during the open ﬁeld test (total 90min). n= 15 male mice from
each genotype, two-way ANOVA, F (1, 252)= 2.199, P= 0.1393 between
genotypes. n.s., not signiﬁcant. b There is no difference between Igsf21+/+
and Igsf21−/− littermates in latency to fall in the rotarod test. n= 15 male
mice from each genotype, two-way ANOVA, F (1, 84)= 2.217, P= 0.1402
between genotypes. n.s., not signiﬁcant. c There is no difference
between Igsf21+/+ and Igsf21−/− littermates in mean startle amplitudes
in the pulse-alone trials for the three test blocks (Block I: 6 consecutive
pulse-alone trials; Block II, 8 pulse-alone trials interspersed with prepulse
+pulse trials; Block III: 6 consecutive pulse-alone trials). n= 15 male mice
from each genotype, two-way ANOVA, F (1, 84)= 2.663, P= 0.1064
between genotypes. n.s., not signiﬁcant. d Igsf21−/− mice display decreased
pre-pulse inhibition (PPI). (Block II PPI, n= 15 male mice for each genotype,
two-way ANOVA, F (1, 140)= 8.348, *P= 0.0045 between genotypes.
#P= 0.0368 at 79 dB between the two genotypes by Bonferroni’s multiple
comparisons test). Data are presented as mean± s.e.m
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collectively suggest that inhibitory synapses of Igsf21−/− CA1
neurons have defective presynaptic release of GABA but
normal functional GABA receptor density at their postsynaptic
sites. The uncoordinated presynaptic and postsynaptic
organization induced by IgSF21 knockout could be due to an
imbalance in bidirectional trans-synaptic signaling via NRX2α:
NRX2α acts as a receptor that mediates presynaptic organization
signals induced by postsynaptic organizers such as NLGs19, 22,
calsyntenin-335 and IgSF21 but also acts as a ligand that
induces postsynaptic organization, the signals of which are
mediated by postsynaptic organizers such as NLGs22, 48.
Further, IgSF21 binds to NRX2α at its LNS1 domain
whereas NLGs binds to its LNS6 domain19, 22, suggesting that
IgSF21 and NLGs regulate NRX2α functions through interacting
with distinct domains of NRX2α. Thus, IgSF21 may play a role
in balancing the bidirectional trans-synaptic roles of NRX2α
for coordinated presynaptic and postsynaptic organization of
inhibitory synapses by cooperating with other NRX2α-interacting
organizers.
Igsf21 is a vertebrate-speciﬁc gene with no paralogs and
our data show its signiﬁcant expression in the brain.
Further Igsf21−/− mice exhibit sensorimotor gating deﬁcits,
which has also been demonstrated in several different mutant
mouse lines with GABAergic signaling deﬁcits49–51 and detected
in patients with neuropsychiatric disorders, particularly
schizophrenia39–41. These data suggest that IgSF21 may be
involved in brain functions through the regulation of inhibitory
presynaptic organization. Given that the ventral hippocampus
is one of the brain regions involved in the regulation of
sensorimotor gating52, impaired organization of GABAergic
synapses in the ventral hippocampus may underlie the
sensorimotor gating deﬁcits of Igsf21−/− mice. Interestingly,
deletion or alteration of the IgSF21-binding partner NRX2α in
both mice and humans results in behavioral changes: NRX2α
knockout mice exhibit autism-like and anxiety-like behaviors53, 54
and the human NRXN2 gene encoding NRX2α is associated
with ASD and schizophrenia55. Therefore, it would be important
for future studies to more comprehensively characterize
behavioral phenotypes of Igsf21−/− mice and/or region-speciﬁc
Igsf21 knockout mice and also to sequence the IGSF21 gene locus
in human patients with schizophrenia, ASDs and anxiety
disorders.
In conclusion, we identiﬁed IgSF21-NRX2α as a novel synapse
organizing complex speciﬁc to inhibitory synapses. In the
hippocampal CA1 region, IgSF21 controls the organization of
inhibitory presynaptic terminals mainly in the stratum radiatum.
Our study thus identiﬁes and characterizes a novel and
unique molecular mechanism underlying inhibitory presynaptic
organization, providing molecular insights into how
complex GABA-mediated synaptic inhibition is established and
regulated.
Methods
Plasmids. Rat IgSF21 (amino acid (aa) 1–468, NM_001271454.1) was isolated
from a rat brain full-length cDNA library23 by performing a ﬁbroblast-neuron
coculture screen (Supplementary Fig. 1a, b). Mouse IgSF21 (aa 1–468,
NM_198610.2) and IgSF21-S (aa 1–271, XM_006538799.3) were cloned by
RT-PCR from mouse brain RNA extracts and subcloned into pBluescript II SK. For
IgSF21-HA, an HA epitope coding sequence was inserted in frame 4 aa residues
upstream of the putative C-terminal GPI anchor signal sequence. For mammalian
expression controlled by the pCAG promoter, the coding region of the tagged
constructs was subcloned into pCAG-EGFP (Addgene) between EcoRI and NotI,
replacing the EGFP coding region. IgSF21 deletion constructs were generated by
inverse PCR using mouse IgSF21-HA as the template to delete the regions
encoding aa 31–141 (IgSF21ΔIg1) or aa 348–431 (IgSF21ΔIg2). A series of
extracellularly HA-tagged neurexin (HA-NRX) constructs, HA-CD4 and
HA-NLG2 were previously described29, 56. For the pDisplay-NRX2α constructs,
the following coding regions of NRX2αS1–S4(+) were subcloned into pDisplay
(Invitrogen): aa 29-199 (LNS1), aa 29-309 (LNS1-EGF1), aa 29-499 (LNS1-LNS2)
and aa 29-680 (LNS1-LNS3). For IgSF21-Fc and NRX2α-Fc, the ectodomain
regions of rat IgSF21 (aa 1–448) and mouse NRX2αS1–S4(+) (aa 1–1436) were
subcloned into pc4-sp-Fc27 between the HindIII and EcoRI sites. All constructs
were veriﬁed by DNA sequencing.
Cell cultures, transfection and immunocytochemistry. Cultures of rat
hippocampal and cortical neurons, COS-7 cells (ATCC) and HEK293 cells
(ATCC), artiﬁcial synapse formation assay by coculture of COS-7 or HEK293
cells with neurons and immunocytochemistry were performed essentially as
described27, 29. These cell lines were tested for mycoplasma contamination and
experiments were performed under mycoplasma-free conditions.Transfections into
COS-7 cells and HEK293 cells were performed using TransIT-LT1 (Mirus Bio.
LLC). For transfections into hippocampal neurons, the ProFection Mammalian
Transfection System (Promega) was used. Cultures were ﬁxed with paraﬁx solution
(4% paraformaldehyde and 4% sucrose in phosphate-buffered saline (PBS)
(pH 7.4)) for 12 min followed by permeabilization with PBST (PBS + 0.2% Triton
X-100). The following primary antibodies were used for immunocytochemistry:
anti-synapsin I (1:1000; rabbit; AB1543P; Millipore), anti-VGAT (1:1000; rabbit;
131 003; Synaptic Systems), anti-VGLUT1 (1:1000; guinea pig; AB5905; Millipore
for coculture assays, or rabbit; 135 302, Synaptic Systems for IgSF21-HA
localization assays, or mouse IgG1; 317G6, Synaptic Systems for bead assays),
anti-gephyrin (1:1000; mouse IgG1;3B11, Synaptic Systems for coculture assays),
anti-PSD-95 family (1:500; mouse IgG2a; 6G6-1C9, Thermo Scientiﬁc; recognizes
PSD-95, PSD-93, SAP102 and SAP97), anti-Tau-1 (1:2000; mouse IgG2a; PC1C6,
Millipore; recognizes dephosphorylated tau) and anti-HA (1:1000; mouse IgG2b;
12CA5, Roche for artiﬁcial synapse formation assays or 1:5000; rat IgG1; 3F10,
Roche for colocalization analysis). In general, we used highly cross-adsorbed,
Alexa-dye conjugated secondary antibodies generated in goat towards the
appropriate species and monoclonal isotype (1:500; Alexa-488, Alexa-568 and
Alexa-647; Invitrogen) for detection. But, for colocalization analysis using the rat
anti-HA antibody, we used highly cross-adsorbed, Alexa-dye-conjugated secondary
antibodies generated in donkey towards the appropriate species (1:500; Jackson
ImmunoResearch). For labeling dendrites, we used anti-MAP2 (1:6000; chicken
polyclonal IgY; ab5392; Abcam) revealed with AMCA-conjugated anti-chicken IgY
(1:200; donkey IgG; 703–155–155; Jackson ImmunoResearch). To selectively
label surface HA, cultures were ﬁxed in paraﬁx solution, blocked without
permeabilization and then incubated with anti-HA antibody (1:1000) at 4 °C
overnight. For the antibody uptake assay to measure recycling of SVs, live neurons
were incubated with an antibody recognizing the luminal domain of synaptotagmin
(1:500; mouse IgG1; clone 604.2; Synaptic Systems) for 30 min in culture medium
at 37 °C in a 5% CO2 incubator. Images were acquired on a Leica DM6000
ﬂuorescent microscope with a 63 × 1.4 numerical aperture (NA) oil objective
and a Hamamatsu cooled CCD camera using Volocity software (Perkin Elmer).
Images were acquired as 12-bit grayscale and prepared for presentation using
Adobe Photoshop CS5. For quantiﬁcation, sets of cells were stained simultaneously
and imaged with identical settings. For IgSF21-HA colocalization analysis,
images were acquired using a Leica FM6 B microscope with a 100 × 1.4 NA oil
objective and a Hamamatsu C11440 ORCA-Flash 4.0 camera. Images were
acquired as 16-bit grayscale and co-localization of IgSF21-HA puncta with
VGLUT1 or VGAT puncta was analyzed by using Metamorph 7.8 software
(Molecular Devices).
PI-PLC digestion. PI-PLC digestions were performed essentially as described57.
COS-7 cells were transfected with 2 μg of rat IgSF21-HA, washed with PBS 36 h
post-transfection, and incubated in PBS or PBS containing PI-PLC (1 Uml−1;
P-6466; Life technologies) for 1 h at 37 °C. After the incubation, the cells and the
supernatants were collected. For immunoprecipitation of the IgSF21-HA from
supernatants of cultured cells, the supernatant was incubated with anti-HA
(1:300; mouse; clone HA-7; H3663; Sigma) for 2 h at 4 °C and then with Protein G
sepharose (GE Healthcare) for 1 h at 4 °C. The proteins were separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis in 12% gels and
immunodetected using anti-HA antibody (1:2000; rabbit; ab9110; Abcam).
Production of soluble Fc-fusion proteins. Based on previously described
methods27, 29, soluble rat IgSF21 fused to Fc (IgSF21-Fc) and Fc for use as a
negative control were generated using stable HEK293 cell lines transfected with
the corresponding expression vectors with Zeocin-resistant cassettes and
puriﬁed from culture media using Protein G sepharose beads. Soluble neurexin2α
ectodomain fused to Fc (NRX2α-Fc) was generated by transient transfection
into HEK293 cells.
Proteomics screen for IgSF21-interacting proteins. Primary hippocampal
neuron cultures were placed on cell culture dishes coated with poly-L-lysine at a
density of 1.5 × 106 cells per 60-mm dish. We coated 45 μl of Protein A magnetic
beads (Dynabeads, Life Technology) with IgSF21-Fc or Fc protein. Coated beads
were added to the cultured neurons in two 60 mm dishes at 14 days in vitro.
After 24 h, cultures were washed once with D-PBS (including 0.9 mM CaCl2
and 0.49 mM MgCl2) and crosslinked with 1 mM 3,3ʹ-dithiobis (sulfosuccinimidyl
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00333-w ARTICLE
NATURE COMMUNICATIONS |8:  408 |DOI: 10.1038/s41467-017-00333-w |www.nature.com/naturecommunications 11
propionate) (DTSSP; Pierce) in D-PBS. The crosslinked neurons were washed with
D-PBS and incubated with lysis buffer containing 10 mM Tris-HCl, pH 8.0, 10 mM
KCl, 5 mM EDTA, 5 mM EGTA, 0.6% Nonidet P-40 and protease
inhibitors (complete EDTA-free; Roche). Bound proteins were puriﬁed by
magnetic separation (DynaMag-2 Magnet; Life Technologies) and washed three
times with lysis buffer followed by sonication. Bound proteins were further washed
ﬁve times with wash buffer containing 50 mM Tris-HCl, pH 7.5, and 2% SDS
followed by boiling at 98 °C for 5 min. Bound proteins were eluted by boiling in
wash buffer containing 5% 2-mercapto-ethanol, separated by SDS-PAGE and
stained with silver staining for in-gel digestion. The gel lanes were excised into
16 individual fractions. Proteins in each fraction were reduced, alkylated and
digested with trypsin as described58. The resulting peptides were analyzed by
liquid chromatography/tandem mass spectrometry using an LTQ OrbitrapVelos
instrument (ThermoFisher Scientiﬁc, Bremen, Germany) equipped with a
Proxeonnanoelectrospray ion source. For protein identiﬁcation, Mascot
2.5 software (Matrix Science) was used to search the rat Uniprot database.
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE59 partner repository with the
dataset identiﬁer PXD006622 and 10.6019/PXD006622.
Cell surface binding assay. Cell surface binding assays were performed essentially
as described27, 29. COS-7 cells were transfected with the expression vectors for
candidate binding proteins and maintained for 24 h. The transfected COS-7 cells
were washed with extracellular solution (ECS, containing 168 mM NaCl, 2.4 mM
KCl, 20 mM HEPES (pH 7.4), 10 mM D-glucose, 2 mM CaCl2 and 1.3 mM MgCl2)
that contained 100 μg ml–1 bovine serum albumin (BSA) and then incubated with
ECS and BSA containing 100 nM puriﬁed Fc-fusion protein for 1 h at room
temperature. These cells were washed in ECS, ﬁxed with paraﬁx solution, incubated
with blocking solution followed by rabbit anti-HA without permeabilization
and then immunostained with Alexa488-conjugated goat anti-rabbit IgG (H+L)
(1:500; Invitrogen) and Alexa594-conjugated donkey anti-human IgG (H+L)
(1:500; Jackson ImmunoResearch) to label surface HA and bound Fc proteins,
respectively. Images were acquired on a Leica DM6000 ﬂuorescent microscope
with a 40 × 0.75 NA dry objective and a Hamamatsu cooled CCD camera using
Volocity software (Perkin Elmer).
Generation of Igsf21−/− mice. To generate Igsf21 mutant mice, ES cell clones
(Igsf21tm2a(EUCOMM)Hmgu) were obtained from the European Conditional
Mouse Mutagenesis Consortium (Eucomm). In this cell line, the targeting
trapping cassette containing the Engrailed-2 splice acceptor upstream of β-geo
reporter is inserted before a ﬂoxed Igsf21 exon 4. The reporter creates an N-
terminal IgSF21 truncation that does not have any immunoglobulin-like domains.
Homologous recombination in the obtained ES cells was veriﬁed by Southern
blotting. Clone F07 was injected into C57BL/6J blastocysts to generate chimeras in
the same B6 genetic background, and underwent germline transmission by crossing
with C57BL/6J mice to produce the Igsf21−/− line. Igsf21−/− mice were bred into the
C57BL/6 background. Genotyping of Igsf21−/−mice was performed using the
following two primers: P1 (5′-TCA GAC AAT GGT CCC TAT GAG-3′) and
P2 (5′-CTC ATG GCA CTT GCT CCT TG-3′). The expected size of the PCR
products for wild type and mutant genes is 632 and 697 bp, respectively.
Littermates derived from heterozygous parents were used in this study. All animal
experiments were carried out in accordance with the Canadian Council on Animal
Care guidelines and approved by the IRCM Animal Care Committee. Mice
were group-housed (two to ﬁve per cage) and maintained on a 12-h light/dark
cycle (lights on 6:00–18:00).
Synaptosome and PSD preparations and immunoblotting. Puriﬁcation of
synaptic fractions consisting of the crude synaptosome, synaptosome and PSD
fractions from 3- to 4-week-old Igsf21+/+ and Igsf21−/− mice of mixed sex was
performed as described previously23. For all samples, protein concentrations were
measured in DC protein assays (Biorad). After normalizing protein concentration,
samples were run on 10 or 12% polyacrylamide gels. Gels were transferred onto
Immobilon P membranes (Millipore). Membranes were blocked in 5% skim milk
and 0.1% Triton X-100 in PBS and incubated with one of the following primary
antibodies: anti-IgSF21 (1:1000; rabbit; 21465-1-AP; Proteintech), anti-VGAT
antibody (1:10,000; rabbit; 131 003; Synaptic Systems), anti-VGLUT1 (1:5000;
rabbit; 135 302; Synaptic Systems), anti-gephyrin (1:10,000; mouse IgG1; clone
3B11; 147 111; Synaptic Systems), anti-GABAAγ2 (1:3000; rabbit; 224 003; Synaptic
Systems), anti-GABAAα1 (1:100; mouse IgG2a; clone N95/35 supernatant; 73-136;
NeuroMab), anti-PSD-95 family (1:2000; mouse IgG2a; clone 6G6-1C9; MA1-045;
Thermo Scientiﬁc), anti-SynGAP (1:2000; rabbit; 06-900; Millipore (Upstate)),
anti-GluA1 (1:500; mouse IgG1; clone N355/11; 75-327; NeuroMab), anti-GluN2A
(1:1000; rabbit; 07-632; Millipore), anti-GluN2B (1:500; mouse IgG2b; clone
N59/36; 75-101; NeuroMab), anti-neuroligin1 (1:300; mouse IgG1; clone N97A/31;
75-160; NeuroMab), anti-neuroligin2 (1:3000; mouse IgG1; clone 5E6; 129 511;
Synaptic Systems), anti-neuroligin3 (1:300; mouse IgG1; clone N110/29; 75-158;
NeuroMab), anti-synaptophysin (1:10,000; mouse IgG1; clone SY38; MAB5258;
Millipore), anti-synapsin I (1:2000; rabbit; AB1543P; Millipore), anti-neuronal
class III β-Tubulin (1:2000; mouse IgG2a; clone Tuj1;801201; Biolegend),
anti-GFAP (1:2000; Rabbit; Z0334; Dako) and anti-β-actin (1:2000; rabbit; ab8227;
Abcam). Membranes were washed with PBS containing 0.1% Triton X-100
and incubated with one of the following secondary antibodies: HRP-conjugated
anti-mouse IgG (H+L) (1:10,000; 115-035-146; Jackson ImmunoResearch) or
HRP-conjugated anti-rabbit IgG (H+L) (1:10,000; 111-035-144; Jackson
ImmunoResearch). Signals were developed using Immobilon Western
Chemiluminescent HRP Substrate (Millipore) and captured by ImageQuant
LAS 4000 (GE Healthcare). Band signal intensity was measured using Metamorph
7.8 software (Molecular Devices) and normalized to β-actin signal intensity for
quantiﬁcation.
Immunohistochemistry. Immunoﬂuorescence of brain sections was performed on
methanol-ﬁxed fresh frozen brain sections. We anesthetized 4-week-old Igsf21+/+
and Igsf21−/− mouse littermates of mixed sex with ketamine/xylazine and killed
them by transcardial perfusion with PBS (pH 7.4) for blood removal. The brain was
removed from the skull, frozen in O.C.T. compound (Tissue-Tek) on dry ice and
then stored at −80 °C until sectioning. Coronal brain sections (10 µm thick) were
cut using a cryostat (Thermo Scientiﬁc, CryoStar NX70). The sections were
mounted on Superfrost Plus slides and stored at −80 °C. Slides were submerged in a
−20 °C methanol bath for 15 min, then washed three times for 5 min each with
PBS, blocked for 1 h at room temperature with blocking solution (PBS containing
5% BSA (wt/vol), 2.5% normal goat serum (vol/vol), 2.5% normal donkey serum
(vol/vol)) and 0.25% Triton X-100 (vol/vol)). The sections were subsequently
incubated overnight at 4 °C with combinations of the following primary antibodies:
anti-VGAT antibody (1:500; rabbit; 131 003; Synaptic Systems), anti-VGLUT1
(1:2000; guinea pig; AB5905; Millipore), anti-gephyrin (1:1000; mouse; 141 111;
Synaptic Systems) and anti-NeuN (1:500; mouse; clone A60; Millipore). After three
washes with PBS, the sections were incubated for 1 h at room temperature with
combinations of the following highly cross-absorbed secondary antibodies:
Alexa488-conjugated donkey anti-rabbit IgG (1:500; 711-545-152; Jackson
ImmunoResearch), Alexa594-conjugated donkey anti-guinea pig IgG (1:500;
706-585-148; Jackson ImmunoResearch), Alexa594-conjugated donkey anti-mouse
IgG (1:500; 715-585-150; Jackson ImmunoResearch) and Alexa647 goat
anti-mouse IgG (1:500; A21236; Life technologies). After washing with PBS, the
sections were sealed with a mounting reagent (5% DABCO (wt/vol) and 90%
glycerol in 0.02 M Na2HPO4). Confocal images were taken sequentially using a
Leica SP8 microscope with 488, 552 and 638 nm lasers and custom ﬁlter sets
with a 5 × 0.15 NA dry objective for low-magniﬁcation images and a 40 × 1.30
NA oil-immersion objective for high-magniﬁcation images. 12-bit grayscale
images were acquired using Leica Application Suite (LAS) X software at a scan
speed of 400 Hz, and the image dimensions were 2048 × 2048 pixels with a
pixel size of 1.138 μm (5×) or 0.142 μm (40×) and an optical thickness of
51.43 μm (5×) or 1.04 μm (40×).
X-gal staining. Four-week-old Igsf21+/−and Igsf21+/+ littermates were anesthetized
and killed by transcardial perfusion with PBS (pH 7.4) and 4% paraformaldehyde
in PBS. After perfusion, the brain was removed, post-ﬁxed for 3 h in 4%
paraformaldehyde in PBS at 4 °C and cryoprotected in 30% (w/v) sucrose in PBS
for 24 h at 4 °C. The brains were frozen in O.C.T. compound (Tissue-Tek) on dry
ice. Sagittal brain sections (50 μm thick) were cut using a cryostat (Thermo
Scientiﬁc, CryoStar NX70). Free-ﬂoating sections were ﬁxed with 0.2%
glutaraldehyde/PBS for 5 min, washed three times with PBS and then incubated
in 5-bromo-4-chloro-3-indolyl β-D-galactopyranoside (X-gal) working solution
(1 mM MgCl2, 3 mM K4[Fe(CN)6]•3H2O, 3 mM K3[Fe(CN)6], 0.1% Triton X-100,
1 mM X-gal) at 37 °C for 24 h. Sections were washed with 1 mM EDTA/PBS
solution to stop the reaction and sealed with the mounting reagent described above.
Images were acquired using a Leica M165FC microscope with a ×0.63 PlanAPO
objective and a Leica DFC450C digital camera using LASv4.3 software. For
nuclear counterstaining, slices were stained with X-gal and then incubated with
DAPI (100 ng ml–1) in PBS for 30 min at room temperature. Images co-stained
with X-gal and DAPI were acquired using a Leica FM6 B microscope using a
DFC480 camera for the color image and a Hamamatsu C11440 ORCA-Flach
4.0 camera for the ﬂuorescent signal.
Electron microscopy. Twelve littermates (6 Igsf21+/+ and 6 Igsf21−/−, 4 weeks of
age, mixed sex) were anesthetized and perfused transcardially with 4% paraf-
ormaldehyde and 1% glutaraldehyde in 100 mM phosphate buffer (pH 7.4) for
15 min. Brains were removed and post-ﬁxed in the same buffer overnight at 4 °C.
The small pieces (1 × 1 × 1.5 mm) of hippocampus including the
CA1 stratum pyramidale and stratum radiatum were dissected and ﬁxed with
2.5% glutaraldehyde and 4% sucrose in 0.1 M sodium cacodylate buffer
overnight at 4 °C and washed with 0.1 M cacodylate buffer for 1–2 h, followed
by post-ﬁxation with 1% aqueous OsO4 and 1.5% aqueous potassium ferrocyanide
in the same buffer for 2 h at 4 °C. After dehydration with increasing concentrations
of acetone, the samples were embedded in Epon812. To verify the location within
the samples of the stratum pyramidale or the stratum radiatum, 500-nm-thick
sections were prepared with an ultra-microtome and stained with toluidine blue.
Ultrathin sections (90–100 nm thick) were cut using an ultra-microtome and
stained with 4% uranyl acetate and Reynold’s lead. Images of the CA1 stratum
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pyramidale (> 30) and stratum radiatum (> 50) were obtained using an FEI Tecnai
12 BioTwin 120 kV transmission electron microscope equipped with an AMT
XR80C CCD Camera System (Philips). The ﬁnal magniﬁcation of the captured
images was ×31,330. To quantify synapse number, we combined 10 images as one
ﬁeld for the stratum radiatum and 6 images as one ﬁeld for the stratum pyramidale.
Symmetric and asymmetric synapses and total and docked SVs per bouton were
visually identiﬁed and counted using Metamorph 7.8. SVs observed to be in
physical contact with the presynaptic plasma membrane were deﬁned as
docked vesicles. The SV number data were derived from 117 symmetric and
124 asymmetric synapses in dendritic regions in the Igsf21+/+ stratum radiatum,
117 symmetric and 123 asymmetric synapses in dendritic regions in the Igsf21−/−
stratum radiatum, and 111 and 116 symmetric synapses in perisomatic regions in
the Igsf21+/+ and Igsf21−/−stratum pyramidale, respectively (17–25 synapses per
mouse, 6 mice for each genotype). All images were acquired and analyzed while
blind to genotype.
Electrophysiology. We used 3- to 4-week-old littermate mice of mixed sex for
acute hippocampal slice electrophysiology. Mice were anesthetized and decapitated,
and their brains were rapidly removed and placed in ice-cold dissection solution
saturated with 95% O2 and 5% CO2 and containing (in mM) 87 NaCl, 2.5 KCl,
1.25 NaH2PO4, 7.0 MgCl2, 0.5 CaCl2, 25 NaHCO3, 25 glucose, 1 ascorbic acid, 3
pyruvic acid and 75 sucrose (295 mOsmol). A block of tissue containing the
hippocampus was prepared and transverse hippocampal slices (300 μm thick) were
cut in ice-cold dissection solution using a vibratome (Leica VT1000S). Slices were
transferred to a prechamber (Warner Instruments, BSC-PC) ﬁlled with oxygenated
artiﬁcial cerebrospinal ﬂuid (ACSF) containing (in mM) 126 NaCl, 2.5 KCl,
1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, 26 NaHCO3 and 10 glucose (295–305 mOsmol),
allowed to recover ﬁrst for 30 min at 30 °C and then at room temperature for 1 h.
For recording, slices were transferred to a submerged recording chamber
continuously perfused (2 ml min−1) with oxygenated ACSF maintained at
28± 0.5 °C. For mEPSC recordings, CA1 pyramidal neurons were voltage clamped
at −70 mV. Recording pipettes (4–6MΩ) were ﬁlled with solution containing
(in mM) 130 Cs-methanesulfonate, 5 CsCl, 2 MgCl2, 10 EGTA, 10 HEPES, 5
phosphocreatine 2 ATP(tris) and 0.4 GTP (tris), with the pH adjusted to 7.2–7.4 by
CsOH(~290 mOsmol). During mEPSC recording, tetrodotoxin (TTX; 500 nM;
Alomone) and gabazine (20 μM; Tocris) were added to the ACSF to block
action potentials and GABAA receptor-mediated inhibitory synaptic currents,
respectively. For mIPSC recordings, CA1 pyramidal neurons were voltage clamped
at −70 mV and the recording pipette was ﬁlled with solution containing (in mM)
125 CsCl, 0.1 CaCl2, 1 MgCl2, 10 HEPES, 10 EGTA, 4 ATP (Mg2+ salt), 0.3 GTP
(Na+ salt), with the pH adjusted to 7.2–7.4 using CsOH and the osmolality
adjusted to ~290 mOsmol. The recording solution used to isolate mIPSCs
contained NBQX (10 µM; Tocris), DL-AP5 (50 µM; Tocris) and TTX (500 nM;
Alomone) to block excitatory synaptic transmission and action potentials.
Synaptic currents were recorded using an EPC-10 patch-clamp ampliﬁer
(HEKA Electronics), ﬁltered at 2.9 kHz with a Bessel ﬁlter and digitized at 10 kHz.
The frequency and amplitude of mEPSCs and mIPSCs were analyzed using
MiniAnalysis software (Synaptosoft Inc.). For all experiments and analysis, the
experimenter was blind to genotype.
Behavioral experiments. All behavioral experiments were approved by both
the McGill University Animal Care Committee and the IRCM Animal Care
Committee and performed between 8:00 and 18:00 by experimenters blind to
genotype. The same group of mice (15 Igsf21+/+ and 15 Igsf21−/− male littermates
at 6–11 postnatal weeks) was used in all behavioral experiments. Mice were
maintained in a 12-h light/dark cycle (lights on 8:00–20:00 at the Douglas
Mental Health University Institute) in a room at 19–22 °C. Data analysis for
all tests was also performed while blind to genotype.
For open ﬁeld test, locomotor activity boxes containing infrared sensors
(AccuScan Instruments, Columbus, OH, USA) were adapted for use with mice
by placing inserts that divide the space into four equal parts (20 × 20 × 29.5 cm).
Mice were placed in the center of the chamber and allowed to explore freely for a
total of 90 min. To assess locomotor activity, the total distance (cm) travelled in
each 10-minute period was measured.
Rotarod testing was performed using a ﬁve-station rotarod treadmill
(Model LE-8500, Harvard Apparatus Canada). Mice were placed on a rotating rod
and were ﬁrst trained on the apparatus for ﬁve 2-min trials at an interval of 10 min
and a constant speed of 4 r.p.m. After the training, three test trials were performed.
During the test trials, the speed of rotation was gradually increased at 0.3 r.p.m.
per second from 4 to 40 r.p.m. Trials terminated when the animals fell from the
rotating rod or after a maximum time of 5 min. The mean over the three test
trials of the time spent on the rod was taken as the measure of performance in
this test.
Testing of acoustic startle reﬂex and PPI was conducted in eight startle
chambers (San Diego Instruments, San Diego, CA, USA) each consisting of a
Plexiglas chamber (8 cm diameter, 16 cm long) mounted on a Plexiglas base within
a lit, ventilated and sound-attenuating chamber. A speaker mounted on the ceiling
of the chamber provided the background noise (70 dB) and the prepulse and pulse
stimuli. A piezoelectric strain meter on the base transduced the startle response.
Stabilimeter readings were rectiﬁed, digitized on a 4095 scale and recorded by a
computer. An average of 100 1-ms readings beginning at stimulus onset was used
to measure the startle amplitude. To assess the startle amplitude without a prepulse,
a 120 dB, 30-ms stimulus was presented alone. To assess PPI, this startle stimulus
was preceded by a 30-ms prepulse stimulus at one of 73, 76, 79, 82 or 85 dB.
Each session consisted of a 5-min acclimation period followed by three blocks of
trials. Blocks I and III each consisted of 6 startle trials (no prepulse was presented).
Block II consisted of 38 trials: 8 startle trials, 5 PPI trials at each of the 5 prepulse
intensities and 5 “null” trials in which no stimuli were presented. These trials
were performed with a variable inter-trial interval (5–30 s, average of 15 s) in
random order, with the restriction that no more than 2 trials of the same type
occurred sequentially. For data analysis, we took the average of the 8 startle trials
presented during Block II for each subject to measure the startle response. We
also averaged the 5 PPI trials at each of the 5 different prepulse intensities,
and then expressed these values as a percentage of the average response for
the 8 startle trials using the following formula: [(startle-PPI)/startle] × 100. We
also took the averages of the 6 startle trials in Block I and Block III to detect
genotype-dependent differences in habituation.
Quantitative ﬂuorescence. All imaging and image analysis was done while blind
to the experimental condition. All the data for imaging were collected in random
order. Analysis was performed using Metamorph 7.8. For coculture assays, ﬁelds
for imaging were selected based on the surface HA and phase contrast channels to
detect HA-positive HEK293 cells in a neurite-rich region without considering the
other ﬂuorescence channels. The ﬂuorescence channels corresponding to
presynaptic markers were thresholded and the total intensity of puncta within all
regions positive for both surface HA (labeling transfected HEK293 cells) and
dephospho-tau (labeling axons) but negative for MAP2 (labeling dendrites) was
measured. For IgSF21-HA localization analysis, images from the IgSF21-HA and
presynaptic marker channels were thresholded separately to isolate appropriate
puncta. The association between the presynaptic markers and IgSF21-HA puncta
was deﬁned as the pixel overlap of the thresholded IgSF21-HA image with the
thresholded image of each presynaptic marker. For cell surface binding assays, after
off-cell background was subtracted, the average intensity of bound Fc protein per
COS-7 cell area was measured and normalized to the average intensity of surface
HA signal. For quantitative analysis of brain slices, we determined regions of
interest (ROIs) using NeuN images. Quantiﬁcation of VGAT and VGLUT1 puncta
intensity in the stratum radiatum was performed in the same ROI. VGAT and
VGLUT1 images were thresholded by a constant grayscale value equal to the
average of the automatically calculated threshold level of all analyzed images.
We measured the total intensity of all VGAT or VGLUT1 puncta in each ROI
(total intensity (AU) per μm2) and normalized the intensity values to the mean
value of wild-type control.
Statistical analysis. Statistical comparisons were made using GraphPad Prism 6.
Data with normal distributions were analyzed by parametric tests, whereas data
with non-normal distributions were analyzed by non-parametric tests. For
parametric tests, statistical differences between two groups were calculated with an
assumption of similar variance using two-tailed unpaired or paired t-tests, and
between more than two groups using one-way ANOVA with post hoc Tukey’s
multiple comparisons tests or two-way ANOVA with post hoc Bonferroni’s
multiple comparisons tests, as indicated in the ﬁgure legends. For non-parametric
tests, two-tailed Mann–Whitney tests and Kruskal–Wallis one-way ANOVA with
post hoc Dunn’s multiple comparisons tests were used to compare two groups and
more than two groups, respectively, as indicated in the ﬁgure legends. Our sample
sizes were determined based on previous studies in the ﬁeld. All data are reported
as the mean± standard error of the mean (s.e.m.) from three independent
experiments and statistical signiﬁcance was deﬁned as P< 0.05.
Data availability. The data that support the ﬁndings of this study are
available within the article and its Supplementary Information ﬁle, or from the
corresponding author upon request. All raw mass spectrometry proteomics data
are available via ProteomeXchange (http://www.proteomexchange.org/) with
identiﬁer PXD006622 and 10.6019/PXD006622.
Received: 11 December 2016 Accepted: 21 June 2017
References
1. Somogyi, P., Katona, L., Klausberger, T., Lasztoczi, B. & Viney, T. J. Temporal
redistribution of inhibition over neuronal subcellular domains underlies state-
dependent rhythmic change of excitability in the hippocampus. Philos. Trans.
R. Soc. Lond. B. Biol. Sci. 369, 20120518 (2014).
2. Hensch, T. K. Critical period plasticity in local cortical circuits. Nat. Rev.
Neurosci. 6, 877–888 (2005).
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00333-w ARTICLE
NATURE COMMUNICATIONS |8:  408 |DOI: 10.1038/s41467-017-00333-w |www.nature.com/naturecommunications 13
3. Akerman, C. J. & Cline, H. T. Reﬁning the roles of GABAergic signaling during
neural circuit formation. Trends Neurosci. 30, 382–389 (2007).
4. Huang, Z. J. Activity-dependent development of inhibitory synapses and
innervation pattern: role of GABA signalling and beyond. J. Physiol. 587,
1881–1888 (2009).
5. Ben-Ari, Y., Khalilov, I., Kahle, K. T. & Cherubini, E. The GABA excitatory/
inhibitory shift in brain maturation and neurological disorders. Neuroscientist
18, 467–486 (2012).
6. Cline, H. Synaptogenesis: a balancing act between excitation and inhibition.
Curr. Biol. 15, R203–R205 (2005).
7. Nelson, S. B. & Valakh, V. Excitatory/Inhibitory balance and circuit
homeostasis in autism spectrum disorders. Neuron. 87, 684–698 (2015).
8. Klausberger, T. & Somogyi, P. Neuronal diversity and temporal dynamics: the
unity of hippocampal circuit operations. Science 321, 53–57 (2008).
9. DeFelipe, J. et al. New insights into the classiﬁcation and nomenclature of
cortical GABAergic interneurons. Nat. Rev. Neurosci. 14, 202–216 (2013).
10. Monyer, H. & Markram, H. Interneuron diversity series: molecular and genetic
tools to study GABAergic interneuron diversity and function. Trends Neurosci.
27, 90–97 (2004).
11. Huang, Z. J., Di Cristo, G. & Ango, F. Development of GABA
innervation in the cerebral and cerebellar cortices. Nat. Rev. Neurosci. 8,
673–686 (2007).
12. Lewis, D. A., Hashimoto, T. & Volk, D. W. Cortical inhibitory neurons and
schizophrenia. Nat. Rev. Neurosci. 6, 312–324 (2005).
13. Wassef, A., Baker, J. & Kochan, L. D. GABA and schizophrenia: a
review of basic science and clinical studies. J. Clin. Psychopharmacol. 23,
601–640 (2003).
14. Pizzarelli, R. & Cherubini, E. Alterations of GABAergic signaling in autism
spectrum disorders. Neural. Plast. 2011, 297153 (2011).
15. Mohler, H. The GABA system in anxiety and depression and its therapeutic
potential. Neuropharmacology. 62, 42–53 (2012).
16. Dalva, M. B., McClelland, A. C. & Kayser, M. S. Cell adhesion
molecules: signalling functions at the synapse. Nat. Rev. Neurosci. 8, 206–220
(2007).
17. Shen, K. & Scheiffele, P. Genetics and cell biology of building speciﬁc synaptic
connectivity. Annu. Rev. Neurosci. 33, 473–507 (2010).
18. Craig, A. M., Graf, E. R. & Linhoff, M. W. How to build a central synapse: clues
from cell culture. Trends. Neurosci. 29, 8–20 (2006).
19. Sudhof, T. C. Neuroligins and neurexins link synaptic function to cognitive
disease. Nature. 455, 903–911 (2008).
20. Siddiqui, T. J. & Craig, A. M. Synaptic organizing complexes. Curr. Opin.
Neurobiol. 21, 132–143 (2011).
21. Takahashi, H. & Craig, A. M. Protein tyrosine phosphatases PTPδ, PTPσ, and
LAR: presynaptic hubs for synapse organization. Trends Neurosci. 36, 522–534
(2013).
22. Craig, A. M. & Kang, Y. Neurexin-neuroligin signaling in synapse development.
Curr. Opin. Neurobiol. 17, 43–52 (2007).
23. Linhoff, M. W. et al. An unbiased expression screen for synaptogenic proteins
identiﬁes the LRRTM protein family as synaptic organizers. Neuron 61,
734–749 (2009).
24. de Wit, J. & Ghosh, A. Control of neural circuit formation by leucine-rich
repeat proteins. Trends Neurosci. 37, 539–550 (2014).
25. Uemura, T. et al. Trans-synaptic interaction of GluRδ2 and Neurexin through
Cbln1 mediates synapse formation in the cerebellum. Cell 141, 1068–1079
(2010).
26. Yuzaki, M. Cbln1 and its family proteins in synapse formation and
maintenance. Curr. Opin. Neurobiol. 21, 215–220 (2011).
27. Takahashi, H. et al. Postsynaptic TrkC and presynaptic PTPσ function as a
bidirectional excitatory synaptic organizing complex. Neuron 69, 287–303
(2011).
28. Ammendrup-Johnsen, I., Naito, Y., Craig, A. M. & Takahashi, H.
Neurotrophin-3 enhances the synaptic organizing function of TrkC-protein
tyrosine phosphatase σ in rat hippocampal neurons. J. Neurosci. 35,
12425–12431 (2015).
29. Takahashi, H. et al. Selective control of inhibitory synapse development
by Slitrk3-PTPδ trans-synaptic interaction. Nat. Neurosci. 15, 389–398 (2012).
30. Yim, Y. S. et al. Slitrks control excitatory and inhibitory synapse formation with
LAR receptor protein tyrosine phosphatases. Proc. Natl Acad. Sci. USA 110,
4057–4062 (2013).
31. Woo, J. et al. Trans-synaptic adhesion between NGL-3 and LAR
regulates the formation of excitatory synapses. Nat. Neurosci. 12, 428–437
(2009).
32. Poulopoulos, A. et al. Neuroligin 2 drives postsynaptic assembly at perisomatic
inhibitory synapses through gephyrin and collybistin. Neuron 63, 628–642
(2009).
33. Hammer, M. et al. Perturbed hippocampal synaptic inhibition and
γ-oscillations in a neuroligin-4 knockout mouse model of autism. Cell Rep. 13,
516–523 (2015).
34. Chih, B., Engelman, H. & Scheiffele, P. Control of excitatory and inhibitory
synapse formation by neuroligins. Science 307, 1324–1328 (2005).
35. Pettem, K. L. et al. The speciﬁc α-neurexin interactor calsyntenin-3
promotes excitatory and inhibitory synapse development. Neuron 80, 113–128
(2013).
36. Skarnes, W. C. et al. A conditional knockout resource for the genome-wide
study of mouse gene function. Nature 474, 337–342 (2011).
37. Ullrich, B., Ushkaryov, Y. A. & Sudhof, T. C. Cartography of neurexins: more
than 1000 isoforms generated by alternative splicing and expressed in distinct
subsets of neurons. Neuron 14, 497–507 (1995).
38. Harris, K. M. & Weinberg, R. J. Ultrastructure of synapses in the mammalian
brain. Cold Spring Harb. Perspect. Biol. 4, a005587 (2012).
39. Swerdlow, N. R., Braff, D. L. & Geyer, M. A. Cross-species studies of
sensorimotor gating of the startle reﬂex. Ann. N Y Acad. Sci. 877, 202–216
(1999).
40. Braff, D. L. et al. Impact of prepulse characteristics on the detection of
sensorimotor gating deﬁcits in schizophrenia. Schizophr. Res. 49, 171–178
(2001).
41. Kohl, S., Heekeren, K., Klosterkotter, J. & Kuhn, J. Prepulse inhibition in
psychiatric disorders—apart from schizophrenia. J. Psychiatr. Res. 47, 445–452
(2013).
42. Klausberger, T. GABAergic interneurons targeting dendrites of pyramidal cells
in the CA1 area of the hippocampus. Eur. J. Neurosci. 30, 947–957 (2009).
43. Dean, C. et al. Neurexin mediates the assembly of presynaptic terminals. Nat.
Neurosci. 6, 708–716 (2003).
44. Shipman, S. L. & Nicoll, R. A. Dimerization of postsynaptic neuroligin drives
synaptic assembly via transsynaptic clustering of neurexin. Proc. Natl Acad. Sci.
USA 109, 19432–19437 (2012).
45. Um, J. W. et al. Structural basis for LAR-RPTP/Slitrk complex-mediated
synaptic adhesion. Nat. Commun. 5, 5423 (2014).
46. Dobie, F. A. & Craig, A. M. Inhibitory synapse dynamics: coordinated
presynaptic and postsynaptic mobility and the major contribution
of recycled vesicles to new synapse formation. J. Neurosci. 31, 10481–10493
(2011).
47. Tyagarajan, S. K. & Fritschy, J. M. Gephyrin: a master regulator of neuronal
function? Nat. Rev. Neurosci. 15, 141–156 (2014).
48. Kang, Y., Zhang, X., Dobie, F., Wu, H. & Craig, A. M. Induction of GABAergic
postsynaptic differentiation by α-neurexins. J. Biol. Chem. 283, 2323–2334
(2008).
49. Fujihara, K. et al. Glutamate decarboxylase 67 deﬁciency in a subset of
GABAergic neurons induces schizophrenia-related phenotypes.
Neuropsychopharmacology 40, 2475–2486 (2015).
50. Wen, L. et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in
parvalbumin-positive interneurons. Proc. Natl Acad. Sci. USA 107, 1211–1216
(2010).
51. Nguyen, R. et al. Parvalbumin and GAD65 interneuron inhibition in the
ventral hippocampus induces distinct behavioral deﬁcits relevant to
schizophrenia. J. Neurosci. 34, 14948–14960 (2014).
52. Bast, T. & Feldon, J. Hippocampal modulation of sensorimotor processes. Prog.
Neurobiol. 70, 319–345 (2003).
53. Dachtler, J. et al. Deletion of α-neurexin II results in autism-related behaviors
in mice. Transl. Psychiatry 4, e484 (2014).
54. Born, G. et al. Genetic targeting of NRXN2 in mice unveils role in excitatory
cortical synapse function and social behaviors. Front. Synaptic Neurosci. 7, 3
(2015).
55. Gauthier, J. et al. Truncating mutations in NRXN2 and NRXN1 in autism
spectrum disorders and schizophrenia. Hum. Genet. 130, 563–573 (2011).
56. Naito, Y., Tanabe, Y., Lee, A. K., Hamel, E. & Takahashi, H. Amyloid-β
oligomers interact with neurexin and diminish neurexin-mediated excitatory
presynaptic organization. Sci. Rep. 7, 42548 (2017).
57. Diaz-Lopez, A. et al. Characterization of MDGA1, a novel human
glycosylphosphatidylinositol-anchored protein localized in lipid rafts. Exp. Cell
Res. 307, 91–99 (2005).
58. Cloutier, P. et al. High-resolution mapping of the protein interaction network
for the human transcription machinery and afﬁnity puriﬁcation of RNA
polymerase II-associated complexes. Methods 48, 381–386 (2009).
59. Vizcaíno, J. A. et al. 2016 update of the PRIDE database and related tools.
Nucleic Acids Res. 44, D447–D456 (2016).
Acknowledgements
We thank A. Takahashi for excellent preparation of neuron cultures, J. Mui and the
facility for Electron Microscopy Research at McGill University for technical support for
the EM study, and Dr J. Rochford and the Neurophenotyping Centre at the Douglas
Mental Health University Institute for mouse behavioral experiments. We thank
Dr M. Cayouette for comments on the manuscript. This work was supported by
Canadian Institutes of Health Research Grant MOP-133517, a Fonds de la recherche du
Québec Research Scholars (Junior 2) grant and a Scottish Rite Charitable Foundation of
Canada research grant to H.T., Iizuka Takeshi Scholarship Foundation and
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00333-w
14 NATURE COMMUNICATIONS |8:  408 |DOI: 10.1038/s41467-017-00333-w |www.nature.com/naturecommunications
Alzheimer Society Research Program Biomedical Doctoral Awards to Y.N. and the
2016-IRCM-Michel-Bélanger Scholarship to A.K.L.
Author contributions
Y.T. and Y.N performed a majority of the experiments. C.V. performed
electrophysiological experiments. A.K.L. performed coculture assays. Y.S.
performed Southern blotting and subcloning. M.W.L. generated the cDNA library.
H.T. performed the coculture screen, and conceived and supervised the project.
Y.T., Y.N. and H.T. prepared the manuscript with contributions from the
other authors.
Additional information
Supplementary Information accompanies this paper at doi:10.1038/s41467-017-00333-w.
Competing interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2017
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00333-w ARTICLE
NATURE COMMUNICATIONS |8:  408 |DOI: 10.1038/s41467-017-00333-w |www.nature.com/naturecommunications 15
